NEW YORK CITY, New York: At the start of 2025, drug companies raised prices on over 250 brand-name medications in the U.S., including Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's ...
More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...
The price of branded prescription drugs will rise an average of 4.5% in 2025, the same increase as was seen in 2024, ...
Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol ...
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...
Lupin has gained tentative approval from the Food and Drug Administration for abacavir, dolutegravir and lamivudine tablets for oral suspension, 60 mg/5 mg/30 mg, which is a generic of ViiV ...